These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7503093)

  • 1. Chronic intermittent intravenous insulin therapy corrects orthostatic hypotension of diabetes.
    Aoki TT; Grecu EO; Arcangeli MA
    Am J Med; 1995 Dec; 99(6):683-4. PubMed ID: 7503093
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment-induced neuropathy of diabetes related to abrupt glycemic control.
    Stainforth-Dubois M; McDonald EG
    CMAJ; 2021 Jul; 193(28):E1085-E1088. PubMed ID: 34281965
    [No Abstract]   [Full Text] [Related]  

  • 3. [Orthostatic hypotension in diabetes mellitus].
    Lazarov G
    Vutr Boles; 1986; 25(4):10-4. PubMed ID: 3532560
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin for toddlers with difficult diabetes.
    Goonetilleke R; Pollitzer M; Mann N
    Diabetes Care; 2004 Jun; 27(6):1505. PubMed ID: 15161809
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of Devices in Insulin Delivery.
    Meneghini LF; McNulty JN
    Diabetes Technol Ther; 2017 Feb; 19(2):76-78. PubMed ID: 28118052
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of mixing glargine and short-acting insulin analogs on glucose control.
    Kaplan W; Rodriguez LM; Smith OE; Haymond MW; Heptulla RA
    Diabetes Care; 2004 Nov; 27(11):2739-40. PubMed ID: 15505016
    [No Abstract]   [Full Text] [Related]  

  • 7. [Flexible intensive insulin therapy: a change in mentalities].
    Penfornis A; Chabroux S; Grimaldi A
    Rev Med Interne; 2008 Nov; 29(11):857-60. PubMed ID: 18387717
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes.
    Porcellati F; Rossetti P; Ricci NB; Pampanelli S; Torlone E; Campos SH; Andreoli AM; Bolli GB; Fanelli CG
    Diabetes Care; 2007 May; 30(5):1261-3. PubMed ID: 17303785
    [No Abstract]   [Full Text] [Related]  

  • 9. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c: response to Retnakaran et al.
    Blumer I
    Diabetes Care; 2005 Mar; 28(3):763; author reply 763-4. PubMed ID: 15735237
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin-dependent diabetes mellitus in adults.
    Levandoski LA; Santiago JV
    Curr Ther Endocrinol Metab; 1997; 6():418-30. PubMed ID: 9174784
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. Results of the DCCT/EDIC study].
    Liakishev AA
    Kardiologiia; 2006; 46(3):73. PubMed ID: 16710261
    [No Abstract]   [Full Text] [Related]  

  • 12. Prandial insulin and the systemic appearance of meal-derived glucose in people with type 1 diabetes.
    Vella A; Shah P; Basu A; Rizza RA
    Diabetes Care; 2008 Nov; 31(11):2230-1. PubMed ID: 18955720
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic intermittent intravenous insulin therapy: really a new therapeutic option?
    Heinemann L
    Diabetes Technol Ther; 2001; 3(1):125-7. PubMed ID: 11469702
    [No Abstract]   [Full Text] [Related]  

  • 14. Coverage of Prandial Insulin Requirements: An Elusive Goal.
    Heinemann L; Muchmore D
    Diabetes Technol Ther; 2017 Jan; 19(1):7-8. PubMed ID: 28055259
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of insulin delivery devices in diabetes care.
    Garg SK
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S1-3. PubMed ID: 20515296
    [No Abstract]   [Full Text] [Related]  

  • 16. Early insulin: an important therapeutic strategy.
    Dailey GE
    Diabetes Care; 2005 Jan; 28(1):220-1. PubMed ID: 15616256
    [No Abstract]   [Full Text] [Related]  

  • 17. Vanadyl sulfate does not enhance insulin action in patients with type 1 diabetes.
    Aharon Y; Mevorach M; Shamoon H
    Diabetes Care; 1998 Dec; 21(12):2194-5. PubMed ID: 9839120
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhaled insulin product approved.
    Traynor K
    Am J Health Syst Pharm; 2014 Aug; 71(15):1238. PubMed ID: 25027522
    [No Abstract]   [Full Text] [Related]  

  • 19. Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen.
    Mohn A; Strang S; Wernicke-Panten K; Lang AM; Edge JA; Dunger DB
    Diabetes Care; 2000 Apr; 23(4):557-9. PubMed ID: 10857953
    [No Abstract]   [Full Text] [Related]  

  • 20. Devices for insulin administration.
    Hill J
    Nurs Times; 2003 Apr 15-21; 99(15):51-2. PubMed ID: 12733296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.